Saturday, September 23, 2017
Company News: Page (1) of 1 - 09/13/17 Email this story to a friend. email article Print this page (Article printing at page facebook
Global Healthcare Nanotechnology Market - Growth, Trends, and Forecasts 2017-2022 - Research and Markets

(September 13, 2017)

DUBLIN--(BUSINESS WIRE)--The "Global Healthcare Nanotechnology Market - Growth, Trends, and Forecasts 2017 - 2022" report has been added to Research and Markets' offering.

As a market, nanomedicine holds promise owing to its highly precise and reliable nature. Clinical oncology nanomedicine applications dominated the overall market in 2013, however, the cardiovascular nanomedicine market is expected to be the fastest growing segment during the forecast period.

Increasing research funding, growing incidence of cardiovascular diseases, rising geriatric population, awareness of nanomedicine application, high unmet medical needs, and increasing competition by the entry of new players are some of the major drivers for the growth of this market. However, the high costs of nanotechnology-based medical devices and time-consuming product approval are turning out to be restraints for the market.

The applications segment is further segmented into drug delivery, drugs, biomaterials, active implants, in-vitro diagnostics, and in-vivo imaging. Currently, the drug delivery sub-segment holds the larger share as compared to the others because of the higher efficacy of nanomaterials and their ability to cross through the blood with minimum invasiveness and increased bioavailability. This trend is expected to continue throughout the forecast period, as nanoparticles are finding increasing usage in cancer therapy. By disease, the market is sub-segmented into neurological diseases, cardiovascular diseases, oncology, anti-inflammatory, anti-infective, and others, with obesity and diarrhea being the largest sub-segments.

Companies Mentioned:

  • Abbott Laboratories
  • CombiMatrix Corporation
  • GE Healthcare
  • Sigma-Tau Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Mallinckrodt PLC
  • Merck & Company, Inc.
  • Nanosphere, Inc.
  • Pfizer, Inc.
  • Celgene Corporation
  • Teva Pharmaceutical Industries Ltd.
  • UCB (Union chimique belge) S.A.
  • Others

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry Trends

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Global Healthcare Nanotechnology (Nanomedicine) Market -Segmentation

8. Global Healthcare Nanotechnology (Nanomedicine) By Geography - Regional Share and Forecasts

9. Competitive Landscape

10. Company Profiles

11. Analyst Outlook for Investment Opportunities

12. Future Outlook of the Market

For more information about this report visit


Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Healthcare Services, Nanotechnology, Nanomedicine

Page: 1

Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines